Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
48
THC Quote, Financials, Valuation and Earnings
Last price:
$197.86
Seasonality move
:
11.69%
Day range:
$196.68 - $199.85
52-week range:
$109.82 - $222.82
Dividend yield:
0%
P/E ratio:
13.56x
P/S ratio:
0.88x
P/B ratio:
4.33x
Volume:
296.1K
Avg. volume:
954.7K
1-year change:
52.47%
Market cap:
$17.4B
Revenue:
$20.7B
EPS (TTM):
$14.59
Analysts' Opinion
-
Consensus RatingTenet Healthcare Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $237.24, Tenet Healthcare Corp. has an estimated upside of 19.96% from its current price of $197.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $172.00 representing 100% downside risk from its current price of $197.77.
Fair Value
-
According to the consensus of 16 analysts, Tenet Healthcare Corp. has 19.96% upside to fair value with a price target of $237.24 per share.
THC vs. S&P 500
-
Over the past 5 trading days, Tenet Healthcare Corp. has underperformed the S&P 500 by -0.02% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Tenet Healthcare Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tenet Healthcare Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Tenet Healthcare Corp. reported revenues of $5.3B.
Earnings Growth
-
Tenet Healthcare Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Tenet Healthcare Corp. reported earnings per share of $3.86.
Enterprise value:
32.3B
EV / Invested capital:
1.47x
Price / LTM sales:
0.88x
EV / EBIT:
9.65x
EV / Revenue:
1.55x
PEG ratio (5yr expected):
0.01x
EV / Free cash flow:
21.49x
Price / Operating cash flow:
12.22x
Enterprise value / EBITDA:
7.74x
Gross Profit (TTM):
$3.3B
Return On Assets:
7.88%
Net Income Margin (TTM):
11.01%
Return On Equity:
27.14%
Return On Invested Capital:
10.53%
Operating Margin:
15.45%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $20.2B | $21B | $20.9B | $5.1B | $5.3B | |
| Gross Profit | $2.3B | $2.9B | $3.3B | $707M | $817M | |
| Operating Income | $2.3B | $2.9B | $3.3B | $707M | $817M | |
| EBITDA | $3.2B | $3.7B | $4.2B | $916M | $1B | |
| Diluted EPS | $4.45 | $31.25 | $14.59 | $4.88 | $3.86 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $6.9B | $6B | $6.4B | $8.8B | $7.8B | |
| Total Assets | $25.9B | $27.1B | $27.6B | $29.4B | $29.4B | |
| Current Liabilities | $5.4B | $4.3B | $4.4B | $5.5B | $4.6B | |
| Total Liabilities | $22.2B | $22.5B | $22.4B | $21.3B | $20.7B | |
| Total Equity | $3.7B | $4.6B | $5.2B | $8.1B | $8.7B | |
| Total Debt | $14.1B | $15.1B | $15B | $12.9B | $13.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2B | $3.2B | $2.5B | $1B | $1.1B | |
| Cash From Investing | -$1.1B | $3.3B | -$1.4B | $631M | -$385M | |
| Cash From Financing | -$1.1B | -$3.5B | -$2.2B | -$462M | -$323M | |
| Free Cash Flow | $1.1B | $2.4B | $1.5B | $829M | $778M | |
THC
Sector
Market Cap
$17.4B
$28M
Price % of 52-Week High
88.76%
51.03%
Dividend Yield
0%
0%
Shareholder Yield
6.31%
-1.54%
1-Year Price Total Return
52.47%
-17.48%
Beta (5-Year)
1.444
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$197.04
200-day SMA
Buy
Level
$173.05
Bollinger Bands (100)
Buy
Level
181.76 - 207.86
Chaikin Money Flow
Buy
Level
1.1M
20-day SMA
Sell
Level
$203.85
Relative Strength Index (RSI14)
Sell
Level
45.03
ADX Line
Buy
Level
21.48
Williams %R
Neutral
Level
-78.0583
50-day SMA
Sell
Level
$202.97
MACD (12, 26)
Buy
Level
52.02
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Sell
Level
-149.9K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.6844)
Sell
CA Score
(Annual)
Level (-1.5561)
Buy
Beneish M-Score
(Annual)
Level (-2.2647)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.8311)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Ambulatory Care segments. The Hospital Operations segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.
Stock Forecast FAQ
In the current month, THC has received 14 Buy ratings 2 Hold ratings, and 0 Sell ratings. The THC average analyst price target in the past 3 months is $237.24.
-
Where Will Tenet Healthcare Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tenet Healthcare Corp. share price will rise to $237.24 per share over the next 12 months.
-
What Do Analysts Say About Tenet Healthcare Corp.?
Analysts are divided on their view about Tenet Healthcare Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tenet Healthcare Corp. is a Sell and believe this share price will drop from its current level to $172.00.
-
What Is Tenet Healthcare Corp.'s Price Target?
The price target for Tenet Healthcare Corp. over the next 1-year time period is forecast to be $237.24 according to 16 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is THC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tenet Healthcare Corp. is a Buy. 14 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of THC?
You can purchase shares of Tenet Healthcare Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tenet Healthcare Corp. shares.
-
What Is The Tenet Healthcare Corp. Share Price Today?
Tenet Healthcare Corp. was last trading at $197.86 per share. This represents the most recent stock quote for Tenet Healthcare Corp.. Yesterday, Tenet Healthcare Corp. closed at $197.77 per share.
-
How To Buy Tenet Healthcare Corp. Stock Online?
In order to purchase Tenet Healthcare Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get THC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
THC
Sector
P/E ratio
13.56x
23.89x
PEG ratio
0.01x
-0.01x
P/B ratio
4.33x
1.82x
Price / LTM sales
0.88x
1.60x
Growth Metrics
THC
Sector
Revenue growth
3.18%
4.62%
Earnings growth
-20.97%
10.88%
Revenue (5-year growth)
2.26%
6.5%
Earnings forecast
$3.35
-$0.21
Profitability
THC
Sector
Profitability FY 2024
$2.9B
$3.5M
Return on invested capital
10.53%
-31.77%
Return on assets
7.88%
-27.96%
Return on equity
27.14%
-37.63%
Earnings Date
Last Earnings Date
Oct
28
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Jan
27
Balance Sheet
THC
Sector
Total cash
$3B
$26.3M
Short term investments
--
$25.7M
Total assets
$28.9B
$78M
Long term debt
$13.2B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
